Suchergebnisse - "antibodies"

PubPharm (8.502)

71

New drug approval : Pembrolizumab - Neoadjuvant/adjuvant treatment for localized high-risk triple negative breast cancer

enthalten in: Bulletin du cancer | 2022

von Minot-This, M. | Deleuze, A.

72

Epidemiology and the burden of RSV

enthalten in: La Revue du praticien | 2022

von Weil-Olivier, C. | Lorrot, M.

73

Unmet medical need in RSV prevention and future prevention strategies

enthalten in: La Revue du praticien | 2022

von Rozé, C.

74

Evolution of histocompatibility methods in organ transplantation : an update in 2022

enthalten in: Revue medicale de Liege | 2022

von Schmitt, J. | Gothot, A.

75

Paroxysmal vascular acrosyndromes : Practical approach to diagnosis and management

enthalten in: La Revue de medecine interne | 2022

von Senet, P.

76

Benralizumab in cases of eosinophilic granulomatosis with polyangiitis

enthalten in: Revue des maladies respiratoires | 2022

von Carrette, A. | Mercier, V. | Lelubre, C. | +1

77

Contribution of antiphosphatidylserine/prothrombin (anti-PS/PT) antibody detection in the diagnosis and management of antiphospholipid syndrome (APS)

enthalten in: La Revue de medecine interne | 2022

von Delarue, A. | Dragon-Durey, M. | Darnige, L.

78

New drug approval : Adjuvant Pembrolizumab in clear-cell renal-cell carcinoma at high risk for recurrence after nephrectomy

enthalten in: Bulletin du cancer | 2022

von Brunet, M. | Malouf, G.

79

Epstein-Barr Virus and systemic lupus : Which connections?

enthalten in: La Revue de medecine interne | 2022

von Enfrein, A. | Hamidou, M.

80

New drug approval : Pembrolizumab plus lenvatinib in second line for patients with advanced or recurrent endometrial cancer

enthalten in: Bulletin du cancer | 2022

von De Jesus, C. | Rodrigues, M.